Significant ABO hemolytic disease of the newborn in a group B infant with a group A₂ mother

1.Rosenfield RE. A-B hemolytic disease of the newborn. Analysis of 1480 cord blood specimens, with special reference to the direct anti-globulin test and to the group O mother. Blood 1955; 10:17–28.10.1182/blood.V10.1.17.17Search in Google Scholar

2.Rawson AJ, Abelson NM. Studies of blood group antibodies. IV. Physicochemical differences between iso-anti-A,B and iso-anti-A or iso-anti-B. J Immunol 1960b;85:640–7.Search in Google Scholar

3.Kochwa S, Rosenfield E,Tallal L,et al. Isoagglutinins associated with ABO erythroblastosis. J Clin Invest 1961; 40:874–82.10.1172/JCI104322Search in Google Scholar

4.Mollison PL, Engelfriet CP, Contreas M. Blood transfusion in clinical medicine. 10th ed. Oxford, England: Blackwell Science, 1997:418–20.Search in Google Scholar

5.Ozolek JA, Watchko JF, Mimouni F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatrics 1994;125:87–91.10.1016/S0022-3476(94)70131-8Search in Google Scholar

6.Bhutani VK, Johnson L, Sivieri EM. Predictive ability of predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103:6–14.10.1542/peds.103.1.69917432Search in Google Scholar

7.Mallory D, ed. Immunohematology methods and procedures. lst ed.Rockville,MD:American National Red Cross,1993:M36.Search in Google Scholar

8.Mallory D, ed. Immunohematology methods and procedures. lst ed.Rockville,MD:American National Red Cross, 1993:M123.Search in Google Scholar

9.Vengelen-Tyler V, ed. Technical manual. 13th ed. Bethesda,MD:American Association of Blood Banks, 1999:274–5.Search in Google Scholar

10.Munk-Andersen G. Excess of group O-mothers in ABO-haemolytic disease. Acta Path Microbiol Scand 1958; 42:43–50.10.1111/j.1699-0463.1958.tb01727.x13508246Search in Google Scholar

11.Munk-Andersen G. Demonstration of incomplete ABO-antibody with special reference to its passage through the placenta. I.The content of complete ABO-antibody in umbilical cord serum. Acta Path Microbiol Scand 1956; 39:407–20.10.1111/j.1699-0463.1956.tb05069.x13381489Search in Google Scholar

12.Munk-Andersen G. Demonstration of incomplete ABO-antibody with special reference to its passage through the placenta. II. Value of “partial neutralization.” Acta Path Microbiol Scand 1957; 40:453-64.10.1111/j.1600-0463.1957.tb00061.xSearch in Google Scholar

13.Munk-Andersen G.Further experience with a direct conglutination test for demonstrating in-vivo sensitization of red cells of the newborn with ABO antibody. Acta Path Microbiol Scand 1958; 42:33–42.10.1111/j.1699-0463.1958.tb01726.x13508245Search in Google Scholar

14.Graham H, Morrison M, Casey E. Severe ABO hemolytic disease due to high titer IgG anti-B in an A₂ mother. Vox Sang 1974; 27:363–8.Search in Google Scholar